You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 20, November 28, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Toward Optimal Laboratory Use
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Method of Determination Must Be Considered in Interpreting Blood Cholesterol Levels

David W. Blank, MD, FRCP(C); Jeffrey M. Hoeg, MD; Martin H. Kroll, MD; Mark E. Ruddel, MS

JAMA. 1986;256(20):2867-2870.


Abstract

Based on the results of recent clinical trials, physicians have been encouraged to screen and treat patients for hypercholesterolemia. Since the data from the Lipid Research Clinics (LRC) have been used to define the patient population that should be treated, a comparison of LRC cholesterol results with those obtained with two commonly used clinical laboratory instruments was performed. Both the Technicon SMAC and the Du Pont aca had positive bias compared with the LRC method. Therefore, many patients with cholesterol concentrations greater than 265 mg/dL (6.85 mmol/L) as determined by these routinely used methods have markedly lower levels determined by LRC methods. These findings not only indicate that rigorous interlaboratory standardization is required to conform to LRC reference values, but they also suggest that the clinician should be aware of these methodological considerations when the decision to treat hypercholesterolemia is made.

(JAMA 1986;256:2767-2770)



Author Affiliations

From the Clinical Pathology Department, National Institutes of Health Clinical Center (Drs Blank and Kroll and Mr Ruddel), and the Molecular Disease Branch, National Heart, Lung, and Blood Institute (Dr Hoeg), National Institutes of Health, Bethesda, Md.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Within-Person Fluctuations of Serum Cholesterol and Lipoproteins
Mogadam et al.
Arch Intern Med 1990;150:1645-1648.
ABSTRACT  

Hypercholesterolemia in Elderly Persons: Resolving the Treatment Dilemma
Denke and Grundy
ANN INTERN MED 1990;112:780-792.
ABSTRACT  

How Reliably Can Compact Chemistry Analyzers Measure Lipids?
Kaufman et al.
JAMA 1990;263:1245-1249.
ABSTRACT  

An Isolated Total Cholesterol Level Is Inadequate
Keniston
JAMA 1989;261:3241-3242.
ABSTRACT  

Testing Cholesterol Accuracy: Performance of Several Common Laboratory Instruments
Koch et al.
JAMA 1988;260:2552-2557.
ABSTRACT  

A Prudent Approach to Control of Cholesterol Levels
Fihn
JAMA 1987;258:2416-2418.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.